1,9-dimethylmethylene blue has been researched along with tiludronic acid in 1 studies
| Studies (1,9-dimethylmethylene blue) | Trials (1,9-dimethylmethylene blue) | Recent Studies (post-2010) (1,9-dimethylmethylene blue) | Studies (tiludronic acid) | Trials (tiludronic acid) | Recent Studies (post-2010) (tiludronic acid) |
|---|---|---|---|---|---|
| 81 | 1 | 6 | 123 | 28 | 23 |
| Protein | Taxonomy | 1,9-dimethylmethylene blue (IC50) | tiludronic acid (IC50) |
|---|---|---|---|
| 72 kDa type IV collagenase | Homo sapiens (human) | 7.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Driscoll, N; Duesterdieck-Zellmer, KF; Ott, JF | 1 |
1 other study(ies) available for 1,9-dimethylmethylene blue and tiludronic acid
| Article | Year |
|---|---|
Concentration-dependent effects of tiludronate on equine articular cartilage explants incubated with and without interleukin-1β.
Topics: Animals; Apoptosis; Bone Density Conservation Agents; Cartilage, Articular; Chondrocytes; Dinoprostone; Diphosphonates; Dose-Response Relationship, Drug; Down-Regulation; Glycosaminoglycans; Horse Diseases; Horses; Immunoenzyme Techniques; In Situ Nick-End Labeling; In Vitro Techniques; Interleukin-1beta; Interleukin-6; Interleukin-8; Matrix Metalloproteinases; Methylene Blue; Osteoarthritis; Recombinant Proteins | 2012 |